Answer
The most common side effects of VITRAKVI (larotrectinib sulfate) are increased ALT (36%), increased AST (33%), vomiting (30%), anaemia (28%), constipation (28%), diarrhoea (27%), nausea (24%), fatigue (23%) and dizziness (20%).
Sources for this answer
- Vitrakvi 25 mg hard capsulesBayer plc · emc · SmPC §4.8 Undesirable effects · Version 14Document updated
Sources checked